Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20051435HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20051277HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20035648HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20014193HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20051335HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44023476HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44020669HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44023477HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44014539HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44041242HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TCGA Plot Options
Drug Information
GeneFLT1
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0000029
UniProt IDP17948
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830